{
  "catalogId": "458ad7b4-cff2-4d99-b277-1fbfbdda3d53",
  "name": "NUBEQA 300 MG",
  "status": "",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "167 12 36564 99",
  "treatmentDescriptions": "NUBEQA ,in combination with ADT is indicated for the treatment of adult men with non metastatic castration resistant prostate cancer (nmCRPC) who are at high risk of developing metastatic disease NUBEQA is indicated for the treatment of adult patients with metastatic hormone-sensitive prostate cancer (mHSPC) in combination with docetaxel",
  "termsOfIssue": "Prescription required",
  "form": "film coated tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "DAROLUTAMIDE",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L02BB06",
      "name": "DAROLUTAMIDE"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "NUBEQA 300 MG 112 TAB",
      "manufacturer": {
        "name": "באייר",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 112.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER PVC/ALUMINIUM",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "8779",
        "yarpa": "75012",
        "barcode": "7290015876155"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 12445.46544,
        "retailMargin": 10.0,
        "maxRetailPrice": 13690.01198,
        "maxPriceWithVAT": 16154.21342
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T05:57:16.988529"
  }
}